IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo ...
Masimo Corporation MASI recently announced the receipt of the FDA’s 510(k) clearance for its W1 medical watch. The approval allows the watch to be integrated with the Masimo SafetyNet comprehensive ...
Secure Bluetooth® Connectivity Allows Continuous, Accurate Wrist-based Measurements to be Seamlessly Relayed to Caregivers via the Masimo Secure Health Data Cloud IRVINE, Calif.--(BUSINESS WIRE)-- ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), today announced that the Masimo W1 ® Sport advanced health tracking wearable is gaining a powerful new feature: scientifically based sleep ...
Apple convinced a federal jury on Friday that health monitoring tech company Masimo 's smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo's W1 and ...
A federal jury Friday ruled that Masimo's smartwatches infringed on Apple Watch patents, but awarded Apple just $250 in damages, which is the statuary minimum amount Apple could seek while it pursues ...
Scope of the SESHAT Project at Pioneering Hospital, Part of the Catalan Health Institute, Includes Deployment of up to 1,000 Masimo W1 Watches, 100 Radius VSMs, and Numerous Additional Masimo Hospital ...
(Reuters) -Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches infringe two of its design patents as part of a broader intellectual ...
Masimo (Nasdaq:MASI) has opposed an attempt by Apple to overturn the recent patent infringement ruling ordering it to pay $634 million.
The legal battle between Apple and medical technology company Masimo rages on, with the bigger company — sorta, kinda — winning their latest face off. A federal jury has agreed with Apple that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results